First Time Loading...

Myovant Sciences Ltd
NYSE:MYOV

Watchlist Manager
Myovant Sciences Ltd Logo
Myovant Sciences Ltd
NYSE:MYOV
Watchlist
Price: 26.98 USD -0.04% Market Closed
Updated: May 1, 2024

Myovant Sciences Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Myovant Sciences Ltd
Cash from Operating Activities Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Myovant Sciences Ltd
NYSE:MYOV
Cash from Operating Activities
-$269.9m
CAGR 3-Years
-2%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash from Operating Activities
-$160.3m
CAGR 3-Years
-147%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash from Operating Activities
-$145.6m
CAGR 3-Years
-7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash from Operating Activities
-$60.6m
CAGR 3-Years
-50%
CAGR 5-Years
-18%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash from Operating Activities
£2.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash from Operating Activities
£44.6m
CAGR 3-Years
-16%
CAGR 5-Years
4%
CAGR 10-Years
3%

See Also

What is Myovant Sciences Ltd's Cash from Operating Activities?
Cash from Operating Activities
-269.9m USD

Based on the financial report for Dec 31, 2022, Myovant Sciences Ltd's Cash from Operating Activities amounts to -269.9m USD.

What is Myovant Sciences Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-24%

Over the last year, the Cash from Operating Activities growth was -3%. The average annual Cash from Operating Activities growth rates for Myovant Sciences Ltd have been -2% over the past three years , -24% over the past five years .